CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-26 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +4,500 | $1.44 | $6K | 32,823 |
| 2025-06-26 | Bardin Stephen Chief Financial Officer | Purchase | +2,000 | $1.50 | $3K | 3,000 |
| 2025-06-24 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +83,300 | 83,300 | ||
| 2025-06-24 | Bardin Stephen Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2025-06-24 | Stauderman Kenneth A. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +47,125 | 47,125 | ||
| 2025-06-24 | Roberts Eric W CHIEF BUSINESS OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +72,750 | 72,750 | ||
| 2025-06-24 | Dunn Michael J. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +47,125 | 47,125 | ||
| 2025-06-24 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +77,625 | 77,625 | ||
| 2025-06-24 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2025-06-24 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-24 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +4,166 | 4,166 | ||
| 2025-06-24 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2025-06-24 | Glicklich Alan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2025-06-24 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +8,594 | 8,594 | ||
| 2025-06-24 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +26,250 | 26,250 | ||
| 2025-06-24 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 4 of 29 · 565 trades